Senior insider sale
SVP, Diagnostics, clonoSEQ at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$364.0K
15.98K shares
What this filing means
BOBULSKY SUSAN plans to sell 15.98K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $364.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/15/2026ACC: 0001950047-26-009505
Officer· SVP, Diagnostics, clonoSEQ
Since Aug 2020
15.98K
Shares to sell
$364.0K
Approx. market value
1.20K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/4/2024
1.20KTotal acquired1.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2024 | Restricted Stock Units N/A | 1.20K | — |
| Total | 1.20K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
3K
Market value
$75.0K
8/10/2026
—Completed
Units to sell
1.30K
Market value
$31.2K
7/30/2026
—Completed
Units to sell
5K
Market value
$115.0K
7/16/2026
—Completed
Units to sell
487.00
Market value
$10.7K
7/1/2026
—Completed
Units to sell
5K
Market value
$102.5K
6/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.20K
Market value
$29.6K
9/15/2026
Total
Units
15.98K
Value
$364.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/10/2026 | 3K | $75.0K | — | Completed |
7/30/2026 | 1.30K | $31.2K | — | Completed |
7/16/2026 | 5K | $115.0K | — | Completed |
7/1/2026 | 487.00 | $10.7K | — | Completed |
6/25/2026 | 5K | $102.5K | — | Completed |
| Planned — Approximate Date | ||||
9/15/2026 | 1.20K | $29.6K | NASDAQ | Planned |
| Total | 15.98K | $364.0K | ||